Skip to main content
SpringerLink
Log in

End-stage heart failure: Surgical therapy and implantable devices

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Despite recent advances in medical therapy, mortality remains high following the diagnosis of heart failure (HF). Cardiac transplantation is still the standard surgical treatment option for highly selected patients with severe end-stage HF; however, it is available only to a small percentage of patients. The small number of available donor hearts is an inherent limitation on the ability of cardiac transplantation to greatly impact the management of advanced HF. The increased incidence and prevalence of HF in an ever aging and medically complex population has paved the way for alternative surgical and device treatment strategies. Some of these treatment options include ventricular reduction and remodeling surgery, mitral valve repair, mechanical ventricular assist device implantation, implantable cardioverter defibrillators, and cardiac resynchronization therapy. Several recent trials have demonstrated effectiveness of these therapies with regard to improvement in physiologic end points, HF symptoms, and survival. Surgical and device techniques are usually combined with optimal medical management of HF. The total cost and actual cost-effectiveness of employing these new therapeutic modalities in a growing population of HF patients remain to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. 2001 Heart and Stroke Statistical Update. Dallas, TX: American Heart Association; 2000.

  2. O’Connell JB, Bristow MR: Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994, 13:S107-S112.

    PubMed  CAS  Google Scholar 

  3. Ho KKL, Anderson KM, Kannel WB, et al.: Survival after the onset of congestive heart failure in the Framingham Heart Study Subjects. Circulation 1993, 88:107–115.

    PubMed  CAS  Google Scholar 

  4. Patten RD, Udelson JE, Konstam MA: Ventricular remodeling and its prevention in the treatment of heart failure. Curr Opin Cardiol 1998, 13:162–167.

    PubMed  CAS  Google Scholar 

  5. Hunt SA, Frazier OH: Mechanical circulatory support and cardiac transplantation. Circulation 1998, 97:2079–2090. Complete review of approved devices used for mechanical ventricular assist and circulatory support. This review also covers cardiac transplantation and alternative surgical therapies for HF.

    PubMed  CAS  Google Scholar 

  6. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. The SOLVD Investigators [no authors listed]. N Engl J Med 1991, 325:293–302.

  7. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group [no authors listed]. N Engl J Med 1987, 316:1429–1435.

  8. Konstam MA, Mann DL: Contemporary medical options for treating patients with heart failure. Circulation 2002, 105:2244–2246.

    Article  PubMed  Google Scholar 

  9. Pitt B, Poole-Wilson PA, Segal R, et al.: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 2000, 355:1582–1587.

    Article  PubMed  CAS  Google Scholar 

  10. Cohn JN, Tognani G: A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667–1675.

    Article  PubMed  CAS  Google Scholar 

  11. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized intervention Trial in congestive Heart Failure (MERIT-HF). MERIT-HF Study Group [no authors listed]. Lancet 1999, 353:2001–2007.

  12. Packer M, Coats AJ, Fowler MB, et al.: Effect of carvedilol on survival in severe chronic heart failure. Carvedilol Prospective Randomized Cummulative Survival Study Group. N Engl J Med 2001, 344:1651–1658. This prospective randomized controlled study extended the benefits of _-blocker therapy to patients with severe HF.

    Article  PubMed  CAS  Google Scholar 

  13. Pitt B, Zannad F, Remme WJ, et al.: Randomized Aldosterone Evaluaton Study (RALES). N Engl J Med 1999, 341:709–717.

    Article  PubMed  CAS  Google Scholar 

  14. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group [no authors listed]. N Engl J Med 1997, 336:525–533.

  15. 2001 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry for Transplant Recipients: Transplant Data 1991–2000. Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI: 2001.

  16. Miniati DN, Robbins RC: Heart transplantation: a thirtyyear perspective. Annu Rev Med 2002, 53:189–205.

    Article  PubMed  CAS  Google Scholar 

  17. Hosenpud JD, Bennett LE, Keck BM, et al.: The registry of the International society for heart and lung transplantation: eighteenth official report-2001. J Heart Lung Transplant 2001, 20:805–815.

    Article  PubMed  CAS  Google Scholar 

  18. Batista R: Partial left ventriculectomy—the Batista procedure. Eur J Cardiothorac Surg 1999, 15(suppl 1):S12-S19.

    Article  PubMed  Google Scholar 

  19. McCarthy JF, McCarthy PM, Starling RC, et al.: Partial left ventriculectomy and mitral valve repair for endstage congestive heart failure. Eur J Cardiol Thorac Surg 1998, 13:337–343.

    Article  CAS  Google Scholar 

  20. Dor V, Saab M, Coste P, et al.: Endoventricular patch plasties with septal exclusion for repair of ischemic left ventricle: technique, results, and indications from a series of 781 cases. Jpn J Thorac Cardiovasc Surg 1998, 46:389–398.

    PubMed  CAS  Google Scholar 

  21. Athanasuleas CL, Stanley AW, Buckberg GD, et al.: Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodeled ventricle after anterior myocardial infarction. RESTORE group. Reconstructive endoventricular surgery, returning torsion original radius elliptical shape to the LV. J Am Coll Cardiol 2001, 37:1199–1209. Large study evaluating the safety and efficacy of surgical ventricular restoration in patients with HF. Most patients also received coronary artery bypass surgery (89%) and mitral valve repair (22%). Based on these results, a randomized trial of this surgical therapy is now being conducted.

    Article  PubMed  CAS  Google Scholar 

  22. Bolling SF, Smolens IA, Pagani FD: Surgical alternatives for heart failure. J Heart Lung Transplant 2001, 20:729–733.

    Article  PubMed  CAS  Google Scholar 

  23. Goldstein DJ, Oz MC, Rose EA: Implantable left ventricular assist devices. N Engl J Med 1998, 339:1522–1533.

    Article  PubMed  CAS  Google Scholar 

  24. Sun BC, Catanese KA, Spanier TB, et al.: 100 long-term implantable left ventricular assit devices: the Columbia Presbyterian interim experience. Ann Thorac Surg 1999, 68:688–694.

    Article  PubMed  CAS  Google Scholar 

  25. Rose EA, Gelijns AC, Moskowitz AJ, et al.: Long-term use of a left ventricular assist device for end-stage heart failure. REMATCH Study Group. N Engl J Med 2001, 345:1435–1443.The first randomized trial examining mechanical ventricular assist therapy versus medical therapy for the treatment of patients with end-stage HF. This trial has opened the door for destination therapy as a surgical option for severe HF patients.

    Article  PubMed  CAS  Google Scholar 

  26. Cannom DS, Prystowsky EN: Management of ventricular arrhythmias: detection, drugs, and devices. JAMA 1999, 281:172–179.

    Article  PubMed  CAS  Google Scholar 

  27. Moss AJ, Hall WJ, Cannom DS, et al.: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996, 335:1933–1940.

    Article  PubMed  CAS  Google Scholar 

  28. Buxton AE, Lee KL, Fisher JD, et al.: A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999, 314:1882–1890.

    Article  Google Scholar 

  29. Moss AJ, Zareba W, Hall WJ, et al.: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877–883. Prospective randomized trial demonstrating that implantation of an ICD in patients with a prior myocardial infarction and LV dysfunction improves survival when compared with conventional therapy. Based on these results, prophylactic ICD therapy should now be strongly considered in these patients.

    Article  PubMed  Google Scholar 

  30. Cazeau S, Le Clerq C, Lavergne T, et al.: Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. N Engl J Med 2001, 344:873–880.

    Article  PubMed  CAS  Google Scholar 

  31. Abraham WT, Fisher WG, Smith AL, et al.: Cardiac resynchronization in chronic heart failure. MIRACLE study group. N Engl J Med 2002, 346:1845–1853.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiac Transplantation Program, Tufts-New England Medical Center, 02021, Boston, A, USA

    Mohamad El-Zaru MD & David De Nofrio MD

Authors
  1. Mohamad El-Zaru MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David De Nofrio MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

El-Zaru, M., De Nofrio, D. End-stage heart failure: Surgical therapy and implantable devices. Curr Treat Options Cardio Med 4, 511–520 (2002). https://doi.org/10.1007/s11936-002-0044-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-002-0044-y

Keywords

Search

Navigation